How, when to see two simultaneous meteor showers this week
Be on the lookout for shooting stars and fireballs when two meteor showers — the Lyrids meteor shower and Eta Aquarids shower — will overlap through April 26.
Why it matters: It's the latest astronomical event in an active few weeks of skywatching between last month's Blood Moon total lunar eclipse and April's Pink Moon.
What is the Lyrids meteor shower?
The big picture: The Lyrids meteor shower is one of the oldest known meteor showers and have been observed for 2,700 years, according to NASA.
The first recorded sighting of a Lyrid meteor shower goes back to 687 BC by the Chinese.
The Lyrids come from debris left behind by Comet C/1861 G1 Thatcher.
"Lyrids don't tend to leave long, glowing dust trains behind them as they streak through the Earth's atmosphere, but they can produce the occasional bright flash called a fireball," NASA notes.
Yes, but: NASA notes the meteors are "not as fast or as plentiful as the famous Perseids in August."
When is the Lyrids meteor shower?
The Lyrids shower is active April 17 through April 26, per NASA.
The Lyrids are best viewed in the Northern Hemisphere and the best time to watch are the dark hours after moonset and before dawn, NASA said.
What time does the Lyrids meteor shower peak?
Zoom in: NASA says April 21-22 are the peak night to see the Lyrids.
NASA estimates that 10 to 20 meteors can be seen per hour during the peak.
The intrigue: The Lyrids are known for their fast and bright meteors and can "surprise watchers with as many as 100 meteors seen per hour," NASA said.
Where to see Lyrids meteor shower
What we're watching: The point in the sky from which the Lyrids appear to come is near the constellation Lyra, the harp, NASA explains.
Meteors will appear to "radiate from the area near the star Vega, the brightest star in this constellation."
NASA says to be patient and that "the show will last until dawn, so you have plenty of time to catch a glimpse."
Eta Aquarids meteor shower peak
What's next: The Eta Aquarids meteor shower is active from April 19 through May 28 and peaks on May 5-6, according to the American Meteor Society.
The Eta Aquarids are viewable in both the Northern and Southern hemispheres during the pre-dawn hours, NASA said.
The point in the sky from which the Eta Aquarids appear to come is the constellation Aquarius and meteors appear from one of the brightest stars within the constellation, Aquarii, per NASA.
Meteor shower tips to spot shooting stars
State of play: Here are NASA's tips for viewing meteor showers:
Find an area well away from the city or street lights and bring a sleeping bag, blanket or lawn chair.
Lie flat on your back with your feet facing east and look up, taking in as much of the sky as possible, NASA said.
In less than 30 minutes in the dark, your eyes will adapt and you will begin to see meteors.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Trump looks to axe many NASA space missions that launched from Florida: Here's a look at 6
Dozens of NASA's missions to explore the cosmos could be in jeopardy under a budget proposal from the White House. President Donald Trump's administration, which released an initial budget proposal May 2 for the U.S. space agency, dropped more details Friday, May 30, about just which NASA programs it looks to cancel. All told, the budget request for the next fiscal year proposes slashing NASA funding by nearly 25% – from $24.8 billion to $18.8 billion – mostly by eliminating a significant portion of the agency's science portfolio. Trump's proposal, which would need congressional approval, has been lauded by acting NASA Administrator Janet Petro for "still prioritizing critical science and technology research," she said in a statement. But in its own statement, the Planetary Society called the proposed budget "an extinction-level event for the space agency's most productive, successful, and broadly supported activity: science." A total of 41 science projects would get the ax under the proposal, which would be NASA's biggest single-year cut in the agency's history, according to the Planetary Society, a nonprofit space exploration advocacy organization. Many of the science missions Trump looks to cancel are still in development, while others are extended operations with uncrewed vehicles already deployed to orbit. Many of the missions have launched or would get off the ground from Florida's Space Coast. Here's a look at six different types of space missions, from Mars exploration to future moon landings, that could be under threat if Trump's budget were to go into effect. For years, NASA's Mars Sample Return mission has sought to bring back a collection of rocks that could reveal details about potential past life on the Red Planet. The agency's Perseverance rover has been scooping up and storing intriguing rock samples since it first landed in 2021 in the Jezero Crater. But ballooning costs and mission delays have hampered both NASA and the European Space Agency in executing a plan to actually retrieve and transport the samples to Earth for scientists to study further. Meanwhile, Mars Odyssey and MAVEN are two spacecrafts that have been orbiting Mars for years. All three spacecraft – Perseverance and the two orbiters – launched on rockets from what is now called Cape Canaveral Space Force Station in Cape Canaveral, Florida. While those missions could be eliminated, Trump looks to inject another $1 billion to tap the private sector to help lay the groundwork for future Mars exploration. That includes establishing a new NASA initiative called the Commercial Mars Payload Services Program (CMPS). The program would operate similar to NASA's Commercial Lunar Payload Services program by awarding contracts to private companies that would develop spacesuits, vehicles and other technology aimed at reaching the Red Planet. Launching in 2006 from the Cape Canaveral Air Force Base (now Cape Canaveral Space Force Station,) the New Horizons spacecraft became the first spacecraft to explore Pluto up close when it flew by the dwarf planet and its moons on July 14, 2015. In 2019, the space probe reached the Kuiper belt – a doughnut-shaped region of icy bodies extending far beyond the orbit of Neptune – where it continues to make discoveries about the outer solar system. The Juno probe, meanwhile, continues to reveal new insights into the gas giant Jupiter and its Jovian moons nine years after arriving in 2016. The spacecraft, which launched in August 2011 from Cape Canaveral Air Force Station, recently relayed data unmasking the harsh environments of both Jupiter and its volcanic moon Io. NASA's Space Launch System rocket and Orion space capsule – both seen as centerpieces in the effort to return Americans to the moon – may have their days numbered. The SLS and Orion, which have both launched just once on an uncrewed mission in 2022 from Kennedy Space Center near Cape Canaveral, Florida, are due to play a role in NASA's lunar ambitions under the Artemis campaign. But Trump seeks to phase out both the SLS and the Orion after just two more missions. That means Artemis II astronauts would still ride an Orion capsule around the moon following liftoff using the SLS rocket as early as 2026. NASA's plans also call for Artemis III astronauts aboard the Orion capsule to board a SpaceX Starship while in orbit for a ride to the moon's surface as early as 2027. Four years ago, NASA selected two missions to Venus under its Discovery program, focused on developing spaceflights to study our solar system. DAVINCI is a planned mission managed by the Goddard Space Flight Center in Maryland for an orbiter and atmospheric descent probe to reach Venus. Its counterpart, VERITAS, is another upcoming mission to map the surface of the planet in high resolution that would be managed from NASA's Jet Propulsion Laboratory in California. Both spacecraft would have been the first NASA vehicles to explore Venus since the 1990s. Launched in 2016 from Cape Canaveral, Florida, NASA's OSIRIS-REx, which gathered and returned a sample of asteroid Bennu in September 2023, had been renamed OSIRIS-APophis EXplorer (OSIRIS-APEX) and sent on a path that would allow it to meet up with an infamous asteroid in 2029. That asteroid is name Apophis, and it initially posed a sizable threat to Earth when it was first discovered in 2004 before scientists eventually calculated that its trajectory was harmless. OSIRIS-APEX was meant to spend 18 months mapping the asteroid's surface and analyzing its chemical makeup during a rendezvous with Apophis in June 2029 after the asteroid has a close encounter with Earth. Scientists had considered the mission an invaluable endeavor to allow NASA and other space agency's to build up planetary defense capabilities if a space rock ever posed a threat. The Chandra X-ray Observatory has spent more than 25 years detecting exotic environments in the cosmos to help astronomers understand the structure and evolution of the universe. The space telescope, which launched in 1999 aboard the Space Shuttle Columbia, continues to provide data allowing scientists to make new cosmic discoveries. While the observatory is targeted under Trump's budget proposal, other famous space telescopes like the Hubble Telescope and the James Webb Space Telescope would remain in operation. Contributing: Brooke Edwards, Rick Neale, FLORIDA TODAY Eric Lagatta is the Space Connect reporter for the USA TODAY Network. Reach him at elagatta@ This article originally appeared on Florida Today: Trump's budget targets several NASA missions from Florida: What to know
Yahoo
20 minutes ago
- Yahoo
On This Day 60 Years Ago: The First American Spacewalk
Sixty years ago, NASA astronaut Ed White became the first American to walk in space. The Texas native performed the first spacewalk during the Gemini 4 mission on June 3, 1965. The event occurred over the Pacific Ocean, starting at 3:45 p.m. Eastern Time near Hawaii. The trip lasted 23 minutes, eventually ending over the Gulf. In the end, he had traveled 6,500 miles at a speed of 17,000 miles per hour. White used a handheld maneuvering oxygen jet gun to push himself out of the capsule and move back and forth to the end of a 26-foot-long tether. Once the jet gun fuel expired, White pulled himself back and forth with the tether. When the spacewalk ended, White returned to the capsule, famously stating, 'This is the saddest moment of my life.' The 4-day Gemini mission helped study the effects of prolonged spaceflight. White was the mission pilot, while James McDivitt served as the mission commander.
Business Wire
28 minutes ago
- Business Wire
Redwire Awarded Contract from Aspera Biomedicines to Investigate Cutting-Edge Cancer Treatment in Space
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has been awarded a contract from Aspera Biomedicines, Inc. (Aspera), a pharmaceutical company specializing in the development of cancer stem cell targeted therapies, to conduct space-based research and analysis on a new cancer treatment using Redwire's Pharmaceutical In-space Laboratory (PIL-BOX) technology. Aspera will use this mission to advance development of rebecsinib, a small molecule ADAR1 inhibitor recently approved by the U.S. Food and Drug Administration to begin first-in-human trials. On Earth, scientists have noted an upregulation – or increased rate of expression – of the ADAR1 protein in cancer stem cells as being linked to the accelerated progression of some types of cancer. Researchers at Aspera have analyzed data from two previous spaceflight experiments that showed that rebecsinib can inhibit expression of ADAR1, halting the progression of cancer stem cell propagation in triple-negative breast cancer organoid models. Results from Aspera's prior experiments indicate that rebecsinib could behave as a cancer 'kill switch.' On this mission, Aspera researchers will analyze the crystal structure of ADAR1p150 with and without rebecsinib or intermediates. The results of this analysis could enhance opportunities to develop new drug formulations and a broader array of ADAR1 inhibitors. 'Redwire is excited to facilitate critical space research for Aspera Biomedicines' cutting-edge cancer treatment that could have major implications in the global fight against cancer,' said Redwire's President of In-Space Industries John Vellinger. 'Redwire's PIL-BOX technology continues to be a critical resource for enabling game-changing discoveries to advance human health.' 'At Aspera, it is a privilege to partner with our industrious and innovative colleagues at NASA, CASIS, and Redwire, through a NASA In Space Phase 2 biomanufacturing grant, to utilize microgravity to enhance and accelerate protein crystallization of the target of our FDA IND-approved small molecule inhibitor of the cancer cloning and immune evasion gene, ADAR1p150,' said Aspera's co-founder, Catriona Jamieson. 'We anticipate that this unique partnership combined with the science accelerating environment of the NASA International Space Station will extend the spectrum of small molecule 'cancer kill switches' aimed at preventing cancer stem cell cloning and immune evasion properties that drive relapse, the leading cause of cancer-related mortality.' With 28 units flown and processed to date, PIL-BOX is the premier platform for pharmaceutical researchers, leveraging the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules. Previous PIL-BOX investigations conducted with partners including Bristol Myers Squibb, ExesaLibero Pharma, Eli Lilly and Company, and Butler University have focused on unlocking insights to improve treatments for cardiovascular disease, obesity, and diabetes. The Aspera cancer treatment investigation is slated to launch later this year. About Redwire Redwire Corporation (NYSE:RDW) is a global space infrastructure and innovation company enabling civil, commercial, and national security programs. Redwire's proven and reliable capabilities include avionics, sensors, power solutions, critical structures, mechanisms, radio frequency systems, platforms, missions, and microgravity payloads. Redwire combines decades of flight heritage and proven experience with an agile and innovative culture. Redwire's approximately 750 employees working from 17 facilities located throughout the United States and Europe are committed to building a bold future in space for humanity, pushing the envelope of discovery and science while creating a better world on Earth. For more information, please visit About Aspera Biomedicines Aspera Biomedicines was founded in San Diego in 2020 to develop cancer stem cell targeting small molecule inhibitors together with platform technologies that detect normal stem cell fitness and precancer and cancer stem cell development. With the California Institute for Regenerative Medicine (CIRM), NASA, and angel investor support, Aspera is the first company to develop an FDA IND approved small molecule inhibitor of ADAR1 splicing for myelofibrosis and acute myeloid leukemia that may also have implications for preventing recurrence and immune evasion in 20 cancers. By using microgravity to accelerate tumor growth with NASA and CASIS supported platforms as well as a dedicated collaborative partnership with Axiom Space, Aspera aims to investigate an expanded group of tumor indications for rebecsinib in patient derived tumor organoids to prevent the leading causes of cancer mortality—therapeutic resistance-related recurrence and metastases.
